Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe.
The aim of this trial is to investigate the efficacy of insulin aspart compared to soluble
human insulin on blood glucose control in children below 7 years of age with type 1 diabetes.